| 000 | 01639 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517084408.0 | ||
| 264 | 0 | _c20161114 | |
| 008 | 201611s 0 0 eng d | ||
| 022 | _a1791-7530 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMorinaga, Soichiro | |
| 245 | 0 | 0 |
_aLocked Nucleic Acid In Situ Hybridization Analysis of MicroRNA-21 Predicts Clinical Outcome in Patients After Resection for Pancreatic Cancer Treated with Adjuvant Gemcitabine Monotherapy. _h[electronic resource] |
| 260 |
_bAnticancer research _cMar 2016 |
||
| 300 |
_a1083-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCarcinoma, Pancreatic Ductal _xdrug therapy |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 |
_aDeoxycytidine _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Situ Hybridization |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMicroRNAs _xgenetics |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOligonucleotides _xgenetics |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aNakamura, Yoshiyasu | |
| 700 | 1 | _aAtsumi, Yohei | |
| 700 | 1 | _aMurakawa, Masaaki | |
| 700 | 1 | _aYamaoku, Koichiro | |
| 700 | 1 | _aAoyama, Toru | |
| 700 | 1 | _aKobayashi, Satoshi | |
| 700 | 1 | _aUeno, Makoto | |
| 700 | 1 | _aMorimoto, Manabu | |
| 700 | 1 | _aYokose, Tomoyuki | |
| 700 | 1 | _aMiyagi, Yohei | |
| 773 | 0 |
_tAnticancer research _gvol. 36 _gno. 3 _gp. 1083-8 |
|
| 999 |
_c25827600 _d25827600 |
||